A dendritic cell-targeted chimeric hepatitis B virus immunotherapeutic vaccine induces both cellular and humoral immune responses in vivo

References

• World Health Organization. Global Hepatitis Report 2017. https://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/.
   Google Scholar
• Gerlich WH. Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives. Med Microbiol Immunol. 2015;204(1):39–55. doi:10.1007/s00430-014-0373-y.
   PubMed Web of Science ®Google Scholar
• Suk-Fong Lok A. Hepatitis B treatment: what we know now and what remains to be researched. Hepatol Commun. 2019;3(1):8–19. doi:10.1002/hep4.1281.
   PubMed Web of Science ®Google Scholar
• Sun D, Zhu L, Yao D, Chen L, Fu L, Ouyang L. Recent progress in potential anti-hepatitis B virus agents: structural and pharmacological perspectives. Eur J Med Chem. 2018;147:205–17. doi:10.1016/j.ejmech.2018.02.001.
   PubMed Web of Science ®Google Scholar
• Konerman MA, Lok AS. Interferon treatment for hepatitis B. Clin Liver Dis. 2016;20(4):645–65. doi:10.1016/j.cld.2016.06.002.
   PubMed Web of Science ®Google Scholar
• Rehermann B, Thimme R. Insights from antiviral therapy into immune responses to hepatitis B and C virus infection. Gastroenterology. 2019;156(2):369–83. doi:10.1053/j.gastro.2018.08.061.
   PubMed Web of Science ®Google Scholar
• Maini MK, Schurich A. The molecular basis of the failed immune response in chronic HBV: therapeutic implications. J Hepatol. 2010;52(4):616–19. doi:10.1016/j.jhep.2009.12.017.
   PubMed Web of Science ®Google Scholar
• Gehring AJ, Protzer U. Targeting innate and adaptive immune responses to cure chronic HBV infection. Gastroenterology. 2019;156(2):325–37. doi:10.1053/j.gastro.2018.10.032.
   PubMed Web of Science ®Google Scholar
• Bertoletti A, Le Bert N. Immunotherapy for chronic hepatitis B virus infection. Gut Liver. 2018;12(5):497–507. doi:10.5009/gnl17233.
   PubMed Web of Science ®Google Scholar
• Li J, Bao M, Ge J, Ren S, Zhou T, Qi F, Pu X, Dou J. Research progress of therapeutic vaccines for treating chronic hepatitis B. Hum Vaccin Immunother. 2017;13(5):986–97. doi:10.1080/21645515.2016.1276125.
   PubMed Web of Science ®Google Scholar
• Kosinska AD, Bauer T, Protzer U. Therapeutic vaccination for chronic hepatitis B. Curr Opin Virol. 2017;23:75–81.
   PubMed Web of Science ®Google Scholar
• Shi X, Jarvis DL. Protein N-glycosylation in the baculovirus-insect cell system. Curr Drug Targets. 2007;8(10):1116–25. doi:10.2174/138945007782151360.
   PubMed Web of Science ®Google Scholar
• Altmann F, Staudacher E, Wilson IB, Marz L. Insect cells as hosts for the expression of recombinant glycoproteins. Glycoconj J. 1999;16(2):109–23. doi:10.1023/A:1026488408951.
   PubMed Web of Science ®Google Scholar
• Chen M, Li YG, Zhang DZ, Wang ZY, Zeng WQ, Shi XF, Guo Y, Guo SH, Ren H. Therapeutic effect of autologous dendritic cell vaccine on patients with chronic hepatitis B: a clinical study. World J Gastroenterol. 2005;11(12):1806–08. doi:10.3748/wjg.v11.i12.1806.
   PubMed Web of Science ®Google Scholar
• Dwarshuis NJ, Parratt K, Santiago-Miranda A, Roy K. Cells as advanced therapeutics: state-of-the-art, challenges, and opportunities in large scale biomanufacturing of high-quality cells for adoptive immunotherapies. Adv Drug Deliv Rev. 2017;114:222–39. doi:10.1016/j.addr.2017.06.005.
   PubMed Web of Science ®Google Scholar
• Ma A, Motyka B, Gutfreund K, Shi YF, George R A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B infection. Manuscript submitted to Human Vaccines and Immunotherapeutics (#0297). 2019.
   Google Scholar
• Estes JD, Wong SW, Brenchley JM. Nonhuman primate models of human viral infections. Nat Rev Immunol. 2018;18(6):390–404. doi:10.1038/s41577-018-0005-7.
   PubMed Web of Science ®Google Scholar
• Messaoudi I, Estep R, Robinson B, Wong SW. Nonhuman primate models of human immunology. Antioxid Redox Signal. 2011;14(2):261–73. doi:10.1089/ars.2010.3241.
   PubMed Web of Science ®Google Scholar
• Wieland SF. The chimpanzee model for hepatitis B virus infection. Cold Spring Harb Perspect Med. 2015;5:6. doi:10.1101/cshperspect.a021469.
   Web of Science ®Google Scholar
• Williamson D. Approaches to modelling the human immune response in transition of candidates from research to development. J Immunol Res. 2014;2014:395302. doi:10.1155/2014/395302.
   PubMed Web of Science ®Google Scholar
• Hein WR, Griebel PJ. A road less travelled: large animal models in immunological research. Nat Rev Immunol. 2003;3(1):79–84. doi:10.1038/nri977.
   PubMed Web of Science ®Google Scholar
• Gerdts V, Littel-van den Hurk S, Griebel PJ, Babiuk LA. Use of animal models in the development of human vaccines. Future Microbiol. 2007;2(6):667–75. doi:10.2217/17460913.2.6.667.
   PubMed Web of Science ®Google Scholar
• Scheerlinck JP, Snibson KJ, Bowles VM, Sutton P. Biomedical applications of sheep models: from asthma to vaccines. Trends Biotechnol. 2008;26(5):259–66. doi:10.1016/j.tibtech.2008.02.002.
   PubMed Web of Science ®Google Scholar
• Ulmer AJ, Scholz W, Ernst M, Brandt E, Flad HD. Isolation and subfractionation of human peripheral blood mononuclear cells (PBMC) by density gradient centrifugation on Percoll. Immunobiology. 1984;166(3):238–50. doi:10.1016/S0171-2985(84)80042-X.
   PubMed Web of Science ®Google Scholar
• Mutwiri G, Watts T, Lew L, Beskorwayne T, Papp Z, Baca-Estrada ME, Griebel P. Ileal and jejunal Peyer’s patches play distinct roles in mucosal immunity of sheep. Immunology. 1999;97(3):455–61. doi:10.1046/j.1365-2567.1999.00791.x.
   PubMed Web of Science ®Google Scholar
• Tsang CH, Mirakhur KK, Babiuk LA, Griebel PJ. Oral DNA immunization in the second trimester fetal lamb and secondary immune responses in the neonate. Vaccine. 2007;25(50):8469–79. doi:10.1016/j.vaccine.2007.09.036.
   PubMed Web of Science ®Google Scholar
• Babiuk S, Tsang C, van Drunen Littel-van den Hurk S, Babiuk LA, Griebel PJ. A single HBsAg DNA vaccination in combination with electroporation elicits long-term antibody responses in sheep. Bioelectrochemistry. 2007;70(2):269–74. doi:10.1016/j.bioelechem.2006.10.003.
   PubMed Web of Science ®Google Scholar
• Lau GK, Suri D, Liang R, Rigopoulou EI, Thomas MG, Mullerova I, Nanji A, Yuen ST, Williams R, Naoumov NV. Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology. 2002;122(3):614–24. doi:10.1053/gast.2002.31887.
   PubMed Web of Science ®Google Scholar
• Rehermann B, Lau D, Hoofnagle JH, Chisari FV. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin Invest. 1996;97(7):1655–65. doi:10.1172/JCI118592.
   PubMed Web of Science ®Google Scholar
• Bertoletti A, Gehring AJ. The immune response during hepatitis B virus infection. J Gen Virol. 2006;87(Pt 6):1439–49. doi:10.1099/vir.0.81920-0.
   PubMedGoogle Scholar
• Boni C, Barili V, Acerbi G, Rossi M, Vecchi A, Laccabue D, Penna A, Missale G, Ferrari C, Fisicaro P. HBV immune-therapy: from molecular mechanisms to clinical applications. Int J Mol Sci. 2019;20(11). doi:10.3390/ijms20112754.
   Web of Science ®Google Scholar
• Trombetta ES, Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol. 2005;23:975–1028. doi:10.1146/annurev.immunol.22.012703.104538.
   PubMed Web of Science ®Google Scholar
• Qi H, Egen JG, Huang AY, Germain RN. Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science. 2006;312(5780):1672–76. doi:10.1126/science.1125703.
   PubMed Web of Science ®Google Scholar
• Bergtold A, Desai DD, Gavhane A, Clynes R. Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity. 2005;23(5):503–14. doi:10.1016/j.immuni.2005.09.013.
   PubMed Web of Science ®Google Scholar
• Park CS, Choi YS. How do follicular dendritic cells interact intimately with B cells in the germinal centre? Immunology. 2005;114(1):2–10. doi:10.1111/j.1365-2567.2004.02075.x.
   PubMed Web of Science ®Google Scholar
• Wykes M, Pombo A, Jenkins C, MacPherson GG. Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J Immunol. 1998;161:1313–19.
   PubMed Web of Science ®Google Scholar
• MacPherson G, Kushnir N, Wykes M. Dendritic cells, B cells and the regulation of antibody synthesis. Immunol Rev. 1999;172:325–34. doi:10.1111/imr.1999.172.issue-1.
   PubMed Web of Science ®Google Scholar
• Caminschi I, Lahoud MH, Shortman K. Enhancing immune responses by targeting antigen to DC. Eur J Immunol. 2009;39(4):931–38. doi:10.1002/eji.v39:4.
   PubMed Web of Science ®Google Scholar
• Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science. 2005;307(5715):1630–34. doi:10.1126/science.1108003.
   PubMed Web of Science ®Google Scholar
• Manca F, Fenoglio D, Li Pira G, Kunkl A, Celada F. Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies. J Exp Med. 1991;173(1):37–48. doi:10.1084/jem.173.1.37.
   PubMed Web of Science ®Google Scholar
• Hailemichael Y, Dai Z, Jaffarzad N, Ye Y, Medina MA, Huang XF, Dorta-Estremera SM, Greeley NR, Nitti G, Peng W, et al. Persistent antigen at vaccination sites induces tumor-specific CD8(+) T cell sequestration, dysfunction and deletion. Nat Med. 2013;19(4):465–72. doi:10.1038/nm.3105.
   PubMed Web of Science ®Google Scholar